Boozman questions VA use of $5M FY2024 POPCaP funds for broader oncology network
The clip shows Sen. John Boozman at a Senate Veterans' Affairs hearing pressing VA witness Dr. Kelly on FY2024 funding for the Precision Oncology Program for Cancer of the Prostate (POPCaP). Boozman highlights $5 million appropriated to expand sites and academic partnerships, including Little Rock VA-UAMS, and asks if VA followed intent by creating a broader multi-cancer research program instead. Dr. Kelly explains VA drew from the lung precision oncology program model to scale molecular testing and clinical trials via the Cancer Clinical and Research Network (CCRN), requiring prostate cancer work at sites while enabling broader rollout. The witness affirms the $5M supported prostate-focused research expansion.
Source: Senator John Boozman
